Authors: Salha Boulila, Hassane Oudadesse, Bertrand Lefeuvre, Khansa Chaabouni, Fatima Makni-Ayedi, Pascal Pellen, Hafedh El Feki, Allal Barroug, Abdelfattah El Feki
Abstract: The biomaterials are used for many biomedical applications. The main objective of the present work was to investigate the potential role of Bioglass (Melting)- Polyvinyl alcohol (BG (M)-PVA) and Bioglass (Melting)-Polyvinyl alcohol-20%Ciprofloxacin (BG (M)-PVA-20Cip) in regenerative bone capacity. These composites were implanted in the femoral condyles of Wistar rats and compared to that of ovariectomised groups. Our results noted, after the different period of implantation (15, 30, 60 and 90 days), that the Alkaline phosphatase (ALP) and Acid phosphatase (ACP) activities showed an excellent osteoinductive property of BG (M)-PVA, that this phenomena decreased with the presence of ciprofloxacin. Physico-chemical techniques (ICP-OES and SEM) were engaged to highlight the influence of antibiotic on the structure, porosity and bioactivity of a porous Glass-PVA before and after implantation. The results obtained by ICP-OES showed a rapid reduction in silicon (Si) and sodium (Na), and noted an accelerator increase in calcium (Ca) and phosphorus (P) ion concentrations in BG (M)-PVA that the BG (M)-PVA-20Cip. This result is confirmed by SEM. We can conclude that the loading of ciprofloxacin in BG (M)-PVA is characterized by a retard effect of formation of apatitic phase.
163
Authors: Amany A. Mostafa, Doreya M. Ibrahim, Sara I. Korowash, Fawzia Fahim, Hassane Oudadesse
Abstract: Precursors for the preparation of Si-CHA (silicon and carbonate substituted hydroxyl-apatite) were added in stoichiometric composition in amounts either 30 or 50 solid wt. % to a solution of gelatin to form hybrid nano-composite scaffolds (B(G/Si-CHA)). Temperature was maintained at 40°C and pH at 8 during the reaction. Glutaraldehyde was added to complete the cross-linking then washed. Thereafter, glycine was added to the product to get rid of any glutaraldehyde remnants. Both, 30 and 50% obtained scaffolds were compared with ones containing the same proportions from previously prepared nano powders of the Si-CHA named (C(G/Si-CHA)). The four types and a control one made of gelatin alone (G) were examined by X-ray diffraction (XRD), infrared spectroscopy (FTIR), transmission and scanning electron microscopy (TEM & SEM) and mercury porosimeter. In vitro study was carried out on the prepared scaffolds by immersing in simulated body fluid (SBF) solution for different periods between 1and 28 days. The change in the percentage of the different ions with time in the solutions was followed. Results of IR showed the reaction of the carboxylic groups of gelatin with the added ingredients giving a homogeneous distribution of the inorganic phase formed (Si-CHA). High porosity reaching 94% was achieved with macro and micro pores without the addition of a porogen material.
233
Authors: Joël Fauré, Richard Drevet, Sylvain Potiron, Doina Margareta Gordin, Hassane Oudadesse, T. Gloriant, Hicham Benhayoune
Abstract: Titanium alloys used in orthopedic surgery are usually coated with hydroxyapatite to improve their biocompatibility and osseointegration. Bioactive glasses (BGs) are an interesting alternative to hydroxyapatite for the production of prosthetic coatings due to their osteoproductive property (Class A bioactivity) and to their resorbability. However the classical techniques used to obtain prosthetic coatings are not suitable in the case of BGs. In this study bioactive glass coatings are obtained by electrophoretic deposition on a Ti12Mo5Ta alloy. These coatings were obtained from ethanol suspensions of two different bioglass powders: a Sol-Gel derived 58S and a Melting-Quenching derived 46S. Scanning electron microscopy observations were used to characterize the coatings (morphology and thickness) and the coating/substrate interfaces. The chemical composition of the coatings was studied by X-ray microanalysis and X-ray maps were performed to characterize the spatial distributions of all elements composing the coatings.
135
Authors: Hassane Oudadesse, F.Z. Mezahi, Abdelhamid Harabi, Nelson Heriberto A. Camargo, G. Cathelineau
Abstract: Bioactive ceramics such as bioactive glasses, calcium carbonate and sintered hydroxyapatite are widely used in biomaterials field because of their high biocompatibility. In this study, natural hydroxyapatite (N-HA) and synthetic Hydroxyapatite (S-HA) were heat treated at 800°C and studied using “in vitro” experiments. Several physicochemical methods like: SRD, FTIR, SEM and ICP-OES were employed to evaluate the effects of the thermal treatment and to compare their behaviour after soaking in the Simulated Body Fluid SBF at different times. The formation of TCP has favours the formation of new phase. Obtained results show that the dissolution occurred more in N-HA than in S-HA and consequently the precipitation of new phosphate phase is more important in N-HA. This is due to the presence of Mg, Sr and Zn in N-HA with concentration higher to that in S-HA.
261
Authors: Hassane Oudadesse, M. Mami, R. Dorbez-Sridi, P. Pellen-Mussi, F. Perez, S. Jeanne, D. Chauvel-Lebret, G. Cathelineau
Abstract: This work is focused on the bioactive glasses obtained by melting and rapid quenching. Two glasses with mineral composition of: 47% SiO2 - 26% CaO - 21% Na2O - 6% P2O5 and 48% SiO2 - 30% CaO - 18% Na2O - 4% P2O5 were investigated. The aim of this study was to establish the kinetics of HCAp layer formation “in vitro” and to control the adhesion and proliferation cells of the two glasses in contact with osseous cells. Obtained results permit to evaluate their chemical reactivity and their bioactivity after immersion in the SBF-K9. Ionic exchanges between biomaterials and SBF liquid during the “in vitro” experiments highlight the differences of the chemical reactivity and bioactivity of 47S6 and 48S4. The structural basis for the effect of cristallinity on the rates of HCA formation in vitro in favour of glasses was also established. The melt derived 47S6 and 48S4 glasses offer to surgeons new compositions with different bioactivity kinetic that bioglassÒ 45S6 and can be adaptable in some other bony pathology.
107